LD 1362 LR 1952(02)
An Act To Fund Opioid Treatment by Establishing an Excise Tax on Manufacturers of Opioids
Fiscal Note for Bill as Amended by Committee Amendment " "
Committee: Taxation
Fiscal Note Required: Yes
Fiscal Note
FY 2019-20 FY 2020-21 Projections  FY 2021-22 Projections  FY 2022-23
Net Cost (Savings)
General Fund $100,000 $0 $0 $0
General Fund $100,000 $0 $0 $0
Other Special Revenue Funds $0 $1,562,500 $3,750,000 $3,750,000
Other Special Revenue Funds $0 $1,562,500 $3,750,000 $3,750,000
Fiscal Detail and Notes
The bill creates an excise tax on a manufacturer of opioids that are distributed in the State.  It includes a one-time General Fund appropriation of $100,000 in fiscal year 2019-20 to the Department of Administrative and Financial Services for computer programming to create a new tax and related forms in the sales tax system.
The bill includes Other Special Revenue Funds allocations to the Department of Health and Human Services of $1,562,500 in fiscal year 2020-21 to support opioid use disorder prevention, treatment and recovery supported by revenue from the new opioid tax.